Gonzalo Ona

Gonzalo Ona is a clinical researcher whose work focuses on the public‑health and clinical implications of psychedelic compound use, with particular emphasis on ayahuasca, 5‑MeO‑DMT and interactions between psychedelics and other psychoactive compounds. He has contributed to large cross‑sectional and population‑level studies characterising health status, psychosocial wellbeing, lifestyle, and coping strategies among ritual ayahuasca users, including cohorts in the Netherlands and broader international samples. These studies emphasise safety signals, patterns of use, and self‑reported mental‑health correlates in non‑clinical and ceremonial settings.

In addition to epidemiology, Ona has been involved in early‑phase experimental and proof‑of‑concept work — for example, pilot randomised trials examining the interactive effects of ayahuasca and cannabidiol on social cognition in healthy volunteers and conceptual papers exploring 5‑MeO‑DMT as a pharmacological model of deconstructed consciousness. His publications frequently appear alongside established investigators in the field and are cited in public‑facing summaries of psychedelic research, reflecting a profile that bridges population studies, translational hypotheses, and small‑scale clinical experimentation.